Logo image of NOCR.CA

NORDEN CROWN METALS CORP (NOCR.CA) Stock Fundamental Analysis

Canada - TSX-V:NOCR - CA6555PC3019 - Common Stock

0.195 CAD
-0.04 (-15.22%)
Last: 5/9/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, NOCR scores 1 out of 10 in our fundamental rating. NOCR was compared to 807 industry peers in the Metals & Mining industry. NOCR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NOCR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NOCR has reported negative net income.
NOCR had a positive operating cash flow in the past year.
In the past 5 years NOCR always reported negative net income.
In the past 5 years NOCR always reported negative operating cash flow.
NOCR.CA Yearly Net Income VS EBIT VS OCF VS FCFNOCR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -439.68%, NOCR is doing worse than 86.20% of the companies in the same industry.
NOCR's Return On Equity of -994.77% is on the low side compared to the rest of the industry. NOCR is outperformed by 75.70% of its industry peers.
Industry RankSector Rank
ROA -439.68%
ROE -994.77%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOCR.CA Yearly ROA, ROE, ROICNOCR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NOCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NOCR.CA Yearly Profit, Operating, Gross MarginsNOCR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

4

2. Health

2.1 Basic Checks

There is no outstanding debt for NOCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NOCR.CA Yearly Shares OutstandingNOCR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
NOCR.CA Yearly Total Debt VS Total AssetsNOCR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

2.2 Solvency

NOCR has an Altman-Z score of -14.89. This is a bad value and indicates that NOCR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NOCR (-14.89) is worse than 72.16% of its industry peers.
There is no outstanding debt for NOCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.89
ROIC/WACCN/A
WACCN/A
NOCR.CA Yearly LT Debt VS Equity VS FCFNOCR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.88 indicates that NOCR may have some problems paying its short term obligations.
The Current ratio of NOCR (0.88) is comparable to the rest of the industry.
A Quick Ratio of 0.88 indicates that NOCR may have some problems paying its short term obligations.
NOCR's Quick ratio of 0.88 is in line compared to the rest of the industry. NOCR outperforms 42.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
NOCR.CA Yearly Current Assets VS Current LiabilitesNOCR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

NOCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1255.65%.
EPS 1Y (TTM)-1255.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1851.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOCR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOCR.CA Price Earnings VS Forward Price EarningsNOCR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOCR.CA Per share dataNOCR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NOCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORDEN CROWN METALS CORP

TSX-V:NOCR (5/9/2025, 7:00:00 PM)

0.195

-0.04 (-15.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)06-03 2025-06-03
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.38%
Ins Owner ChangeN/A
Market Cap5.56M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF 17.36
P/B 9.63
P/tB 9.63
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY5.76%
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -439.68%
ROE -994.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z -14.89
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)119567%
Cap/Depr(5y)74283.6%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1255.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1851.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68%
OCF growth 3YN/A
OCF growth 5YN/A